CYCLOOXYGENASE-2 INHIBITORS: A New Class of Anti-Inflammatory Agents That Spare the Gastrointestinal Tract

This publication has 22 references indexed in Scilit:

• NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
  Published by Elsevier ,2002
• Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.
  Journal of Clinical Investigation, 1994
• Actions and toxic effects of the nonsteroidal anti-inflammatory drugs
  Current Opinion in Rheumatology, 1994
• Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.
  Journal of Clinical Investigation, 1994
• THE GASTRODUODENAL SAFETY AND EFFICACY OF THE FIXED COMBINATION OF DICLOFENAC AND MISOPROSTOL IN THE TREATMENT OF OSTEOARTHRITIS
  Rheumatology, 1992
• The Safety of Arthrotec® in Patients with Rheumatoid Arthritis or Osteoarthritis: An Assessment of the Upper Gastrointestinal Tract by Endoscopy
  Scandinavian Journal of Rheumatology, 1992
• Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response
  Archives of internal medicine (1960), 1987
• ARACHIDONIC ACID METABOLISM
  Annual Review of Biochemistry, 1986
• Effect of dexamethasone on in vivo prostanoid production in the rabbit.
  Journal of Clinical Investigation, 1984
• From experiment to experience: Side effects of nonsteroidal anti-inflammatory drugs
  The American Journal of Medicine, 1983